FOLR1 and ovarian carcinoma: Nonetheless, the antibody, with its high specificity and affinity towards FRα, has limited distribution in normal human tissue [10, 11] and mainly targets the overexpression in epithelial ovarian cancer and non-small cell lung cancer [12, 13].